PHI with Cholecystitis
How does this condition affect your private health insurance?
Gallenblasenentzündung, or Cholecystitis, is the inflammation of the gallbladder, typically caused by gallstones blocking the cystic duct. This blockage leads to bile buildup, pressure, and inflammation. Symptoms include severe upper right abdominal pain, often radiating to the back or shoulder, fever, nausea, and vomiting. Untreated, it can progress to complications like gallbladder rupture, peritonitis, or sepsis. Diagnosis involves physical examination, blood tests, and imaging like ultrasound. Treatment usually involves pain management, antibiotics, and often surgical removal of the gallbladder (cholecystectomy), which is frequently performed laparoscopically, leading to a good prognosis.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically several days to a week with treatment.
Duration of Illness (Lifetime)
Generally a one-time acute event if the gallbladder is surgically removed; otherwise, recurrent episodes are common.
Cost of Treatment (Initial)
Several thousand to tens of thousands of euros, including hospitalization, diagnostics, and potential surgery.
Cost of Treatment (Lifetime)
Minimal after successful cholecystectomy; significantly higher due to recurrent episodes and complications if untreated.
Mortality Rate
Low (under 1%) for uncomplicated cases; higher (up to 10-15%) with severe complications like perforation or sepsis.
Risk of Secondary Damages
Moderate to high without timely treatment, including perforation, peritonitis, sepsis, and acute pancreatitis.
Probability of Full Recovery
Very high (over 90%) with timely and appropriate medical and surgical intervention.
Underlying Disease Risk
Very high (over 90%) presence of gallstones (cholelithiasis); often associated with obesity, high-fat diet, and older age.